Identification of genetic and immune signatures for the recurrence of HER2-positive breast cancer after trastuzumab-based treatment
{{output}}
Purpose: To determine the genetic and immune features associated with the recurrence of human epidermal growth factor receptor2-positive (HER2 +) breast cancer (BC) after trastuzumab-based treatment. ... ...
